Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS: INTI · Delayed Price · USD
0.0900
0.00 (0.00%)
May 29, 2024, 2:37 PM EDT - Market closed
Inhibitor Therapeutics Market Cap
Inhibitor Therapeutics has a market cap or net worth of $15.51 million as of July 3, 2024. Its market cap has increased by 170.02% in one year.
Market Cap
15.51M
Enterprise Value
7.83M
1-Year Change
170.02%
Ranking
n/a
Category
Stock Price
$0.09
Market Cap Chart
Since July 5, 2019, Inhibitor Therapeutics's market cap has decreased from $31.86M to $15.51M, a decrease of -51.32%. That is a compound annual growth rate of -13.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2024 | 13.59M | -14.10% |
| Dec 29, 2023 | 15.83M | -56.38% |
| Dec 30, 2022 | 36.29M | -35.81% |
| Dec 31, 2021 | 56.53M | 330.09% |
| Dec 31, 2020 | 13.14M | -36.64% |
| Dec 31, 2019 | 20.74M | -34.88% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 847.90B |
| Novo Nordisk | 622.30B |
| UnitedHealth Group | 450.56B |
| Johnson & Johnson | 350.56B |
| Merck & Co. | 318.63B |
| AbbVie | 289.79B |
| AstraZeneca | 238.12B |
| Novartis AG | 208.78B |